These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 27252523)

  • 1. E4BP4 is an insulin-induced stabilizer of nuclear SREBP-1c and promotes SREBP-1c-mediated lipogenesis.
    Tong X; Li P; Zhang D; VanDommelen K; Gupta N; Rui L; Omary MB; Yin L
    J Lipid Res; 2016 Jul; 57(7):1219-30. PubMed ID: 27252523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin-induced de novo lipid synthesis occurs mainly via mTOR-dependent regulation of proteostasis of SREBP-1c.
    Dong Q; Majumdar G; O'Meally RN; Cole RN; Elam MB; Raghow R
    Mol Cell Biochem; 2020 Jan; 463(1-2):13-31. PubMed ID: 31541353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GRP78 expression inhibits insulin and ER stress-induced SREBP-1c activation and reduces hepatic steatosis in mice.
    Kammoun HL; Chabanon H; Hainault I; Luquet S; Magnan C; Koike T; Ferré P; Foufelle F
    J Clin Invest; 2009 May; 119(5):1201-15. PubMed ID: 19363290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver-specific expression of transcriptionally active SREBP-1c is associated with fatty liver and increased visceral fat mass.
    Knebel B; Haas J; Hartwig S; Jacob S; Köllmer C; Nitzgen U; Muller-Wieland D; Kotzka J
    PLoS One; 2012; 7(2):e31812. PubMed ID: 22363740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low abundance of insulin-induced gene 1 contributes to SREBP-1c processing and hepatic steatosis in dairy cows with severe fatty liver.
    Zhu Y; Lei L; Wang X; Jiang Q; Loor JJ; Kong F; Chen L; Li J; Zhao C; Liu M; Liu G; Li X
    J Dairy Sci; 2023 Aug; 106(8):5626-5635. PubMed ID: 37291038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic steatosis: a role for de novo lipogenesis and the transcription factor SREBP-1c.
    Ferré P; Foufelle F
    Diabetes Obes Metab; 2010 Oct; 12 Suppl 2():83-92. PubMed ID: 21029304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ursodeoxycholic acid inhibits liver X receptor α-mediated hepatic lipogenesis via induction of the nuclear corepressor SMILE.
    Lee JM; Gang GT; Kim DK; Kim YD; Koo SH; Lee CH; Choi HS
    J Biol Chem; 2014 Jan; 289(2):1079-91. PubMed ID: 24265317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Hexane Fraction of cyperus rotundus Prevents Non-Alcoholic Fatty Liver Disease Through the Inhibition of Liver X Receptor α-Mediated Activation of Sterol Regulatory Element Binding Protein-1c.
    Oh GS; Yoon J; Lee GG; Kwak JH; Kim SW
    Am J Chin Med; 2015; 43(3):477-94. PubMed ID: 25967664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Docosahexaenoic acid inhibits proteolytic processing of sterol regulatory element-binding protein-1c (SREBP-1c) via activation of AMP-activated kinase.
    Deng X; Dong Q; Bridges D; Raghow R; Park EA; Elam MB
    Biochim Biophys Acta; 2015 Dec; 1851(12):1521-9. PubMed ID: 26327595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FoxO1 inhibits sterol regulatory element-binding protein-1c (SREBP-1c) gene expression via transcription factors Sp1 and SREBP-1c.
    Deng X; Zhang W; O-Sullivan I; Williams JB; Dong Q; Park EA; Raghow R; Unterman TG; Elam MB
    J Biol Chem; 2012 Jun; 287(24):20132-43. PubMed ID: 22511764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salt-inducible kinase regulates hepatic lipogenesis by controlling SREBP-1c phosphorylation.
    Yoon YS; Seo WY; Lee MW; Kim ST; Koo SH
    J Biol Chem; 2009 Apr; 284(16):10446-52. PubMed ID: 19244231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cilostazol inhibits insulin-stimulated expression of sterol regulatory binding protein-1c via inhibition of LXR and Sp1.
    Jung YA; Kim HK; Bae KH; Seo HY; Kim HS; Jang BK; Jung GS; Lee IK; Kim MK; Park KG
    Exp Mol Med; 2014 Jan; 46(1):e73. PubMed ID: 24458133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic insulin signaling is required for obesity-dependent expression of SREBP-1c mRNA but not for feeding-dependent expression.
    Haas JT; Miao J; Chanda D; Wang Y; Zhao E; Haas ME; Hirschey M; Vaitheesvaran B; Farese RV; Kurland IJ; Graham M; Crooke R; Foufelle F; Biddinger SB
    Cell Metab; 2012 Jun; 15(6):873-84. PubMed ID: 22682225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interplay between ChREBP and SREBP-1c coordinates postprandial glycolysis and lipogenesis in livers of mice.
    Linden AG; Li S; Choi HY; Fang F; Fukasawa M; Uyeda K; Hammer RE; Horton JD; Engelking LJ; Liang G
    J Lipid Res; 2018 Mar; 59(3):475-487. PubMed ID: 29335275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel JNK2/SREBP-1c pathway involved in insulin-induced fatty acid synthesis in human adipocytes.
    Ito M; Nagasawa M; Omae N; Tsunoda M; Ishiyama J; Ide T; Akasaka Y; Murakami K
    J Lipid Res; 2013 Jun; 54(6):1531-1540. PubMed ID: 23515281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BHLHE40, a third transcription factor required for insulin induction of SREBP-1c mRNA in rodent liver.
    Tian J; Wu J; Chen X; Guo T; Chen ZJ; Goldstein JL; Brown MS
    Elife; 2018 Jun; 7():. PubMed ID: 29952285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin enhances the biogenesis of nuclear sterol regulatory element-binding protein (SREBP)-1c by posttranscriptional down-regulation of Insig-2A and its dissociation from SREBP cleavage-activating protein (SCAP).SREBP-1c complex.
    Yellaturu CR; Deng X; Park EA; Raghow R; Elam MB
    J Biol Chem; 2009 Nov; 284(46):31726-34. PubMed ID: 19759400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coordinated regulation of hepatic FoxO1, PGC-1α and SREBP-1c facilitates insulin action and resistance.
    Sajan MP; Lee MC; Foufelle F; Sajan J; Cleland C; Farese RV
    Cell Signal; 2018 Mar; 43():62-70. PubMed ID: 29269047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Honokiol reverses alcoholic fatty liver by inhibiting the maturation of sterol regulatory element binding protein-1c and the expression of its downstream lipogenesis genes.
    Yin HQ; Kim YC; Chung YS; Kim YC; Shin YK; Lee BH
    Toxicol Appl Pharmacol; 2009 Apr; 236(1):124-30. PubMed ID: 19371623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Smurf1 aggravates non-alcoholic fatty liver disease by stabilizing SREBP-1c in an E3 activity-independent manner.
    Zhang X; Zhan Y; Lin W; Zhao F; Guo C; Chen Y; Du M; Li D; Zhang L; An W; Wang HR; Xie P
    FASEB J; 2020 Jun; 34(6):7631-7643. PubMed ID: 32301540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.